Himalaya Parajuli

632 citations
17 papers · 452 indexed · h-index 10
Topics
MicroRNA in disease regulation (4 papers)Cancer Cells and Metastasis (3 papers)Cancer-related molecular mechanisms research (3 papers)

In The Last Decade

Himalaya Parajuli

16 papers receiving 451 citations

Peers

Himalaya Parajuli
Comparison fields: 5 of 63
  • Molecular Biology 274
  • Oncology 196
  • Cancer Research 136
  • Immunology 69
  • Cell Biology 66
Replace Emilios Gemenetzidis with:
Emilios Gemenetzidis United Kingdom
Barbora Peltanová Czechia
Mariam Gachechiladze Czechia
Jian Xie China
Hemangini H. Vora India
Natascha Cremers Germany
Sharon A. Vantyghem Canada
Ming-Qing Gao South Korea
Yingshe Zhao United States
Rhonda L. Brown United States
Himalaya Parajuli relative to Emilios Gemenetzidis United Kingdom Emilios Gemenetzidis's profile →
Citations per field
00.5×
Emilios Gemenetzidis · 1×
Citations per year

Countries citing papers authored by Himalaya Parajuli

Since Specialization
Citations

This map shows the geographic impact of Himalaya Parajuli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Himalaya Parajuli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Himalaya Parajuli more than expected).

Fields of papers citing papers by Himalaya Parajuli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Himalaya Parajuli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Himalaya Parajuli. The network helps show where Himalaya Parajuli may publish in the future.

Co-authorship network of co-authors of Himalaya Parajuli

This figure shows the co-authorship network connecting the top 25 collaborators of Himalaya Parajuli. A scholar is included among the top collaborators of Himalaya Parajuli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Himalaya Parajuli. Himalaya Parajuli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 0
2 15
3 2
4 3
5 5
6 10
7
Trifluoperazine prolongs the survival of experimental brain metastases by STAT3-dependent lysosomal membrane permeabilization.
16
8 65
9 56
10 32
11 12
12 50
13 44
14 1
15 4
16 4
17 133

About Himalaya Parajuli

Himalaya Parajuli is a scholar working on Immunology and Allergy, Oral Surgery and Cancer Research, having authored 17 papers that have together received 452 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Cancer Cells and Metastasis (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (136 citations), Immunology and Allergy (53 citations) and Oncology (196 citations). Himalaya Parajuli has collaborated with scholars based in Norway, China and United Kingdom. Frequent co-authors include Daniela Elena Costea, Salwa Suliman, A. C. Johannessen, Dipak Sapkota, Johanna Thurlow, Allison Hills, Xiaohong Huang, Muy‐Teck Teh, Max Partridge and Tarig Osman. Their work appears in journals such as Angewandte Chemie International Edition, Biomaterials and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026